Nephrol Dial Transplant (2002) 17: 1402-1407
© 2002 European Renal Association-European Dialysis and Transplant Association
The role of PC-1 and ACE genes in diabetic nephropathy in type 1 diabetic patients: evidence for a polygenic control of kidney disease progression
1 Unit of Endocrinology and 2 Unit for Atherosclerosis and Thrombosis, Scientific Institute ‘Casa Sollievo della Sofferenza’ San Giovanni Rotondo (FG), Italy, 3 Unit for Metabolic Medicine, KCL School of Medicine, Guy's Hospital, London, UK, 4 Diabetes Unit, Hospital ‘Brotzu’, Cagliari, Italy, 5 Chair of Metabolic Medicine, Padua, Italy, 6 Institute of Internal Medicine, Turin, Italy, 7 Institute of Internal Medicine, Endocrine and Metabolic Disease, University of Catania, Garibaldi Hospital, Catania, Italy and 8 Department of Clinical Science, University "La Sapienza", Rome, Italy
Background. The DD genotype of the ACE gene predisposes to faster diabetic nephropathy (DN) progression but its role in DN development is more controversial. We reported previously, in type 1 diabetic patients, an association between faster DN progression and the PC-1 gene Q121 variant, which associates with insulin resistance in non-diabetic subjects. We investigated here whether the combination of the ACE DD genotype and the PC-1 Q121 variant predicts the development and/or progression of DN in type 1 diabetic patients.
Methods. Type 1 diabetic patients either with (n=159) or without (n=122) nephropathy were evaluated in a cross-sectional study. DN was defined as the presence of microalbuminuria or persistent proteinuria in a subject with more than 10-year duration of disease and concomitant diabetic retinopathy, and with no evidence of heart failure or other renal disease. Seventy-five (47 male/28 female) type 1 diabetic patients with nephropathy in whom retrospective information with repeated measurements of serum creatinine was available, were analysed in a longitudinal study.
Results. No association of the PC-1 Q121 variant and the ACE D/D genotype with DN development was observed. However, the ACE DD genotype and the PC-1 Q121 variant were associated, both independently (P=0.02 and P=0.025, respectively) or in combination (P=0.02), with a faster rate of glomerular filtration rate decline. An interaction (P=0.03) was observed between the two genes in increasing the individual patient's risk of being a fast progressor.
Conclusion. Our data suggest that, in type 1 diabetic patients, the ACE and the PC-1 genes interact in increasing the individual risk of having a faster DN progression.
Keywords: albuminuria; end-stage renal failure; gene–gene interaction; gene polymorphism; type 1 diabetes
Correspondence and offprint requests to: Dr Salvatore De Cosmo, Unit of Endocrinology, IRCCS ‘Casa Sollievo della Sofferenza’, I-71013 San Giovanni Rotondo (FG), Italy. Email: endocrinologia{at}operapadrepio.it
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. G. Ewens, R. A. George, K. Sharma, F. N. Ziyadeh, and R. S. Spielman Assessment of 115 Candidate Genes for Diabetic Nephropathy by Transmission/Disequilibrium Test Diabetes, November 1, 2005; 54(11): 3305 - 3318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Young, W. J. Katon, M. Von Korff, G. E. Simon, E. H. B. Lin, P. S. Ciechanowski, T. Bush, M. Oliver, E. J. Ludman, and E. J. Boyko Racial and Ethnic Differences in Microalbuminuria Prevalence in a Diabetes Population: The Pathways Study J. Am. Soc. Nephrol., January 1, 2005; 16(1): 219 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. De Cosmo, R. Trevisan, M. Dalla Vestra, M. Vedovato, A. Argiolas, A. Solini, A. Saller, F. Damone, A. Tiengo, V. Trischitta, et al. PC-1 Amino Acid Variant Q121 Is Associated With a Lower Glomerular Filtration Rate in Type 2 Diabetic Patients With Abnormal Albumin Excretion Rates Diabetes Care, October 1, 2003; 26(10): 2898 - 2902. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Marre A KQ121 variant in the PC-1 gene and diabetic nephropathy: discrepant results between North and South Europe Nephrol. Dial. Transplant., September 1, 2002; 17(9): 1546 - 1547. [Full Text] [PDF]
|
|